Insider Transactions in Q2 2025 at Exelixis, Inc. (EXEL)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 29
2025
|
Bob Oliver Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,812
+18.47%
|
-
|
|
May 29
2025
|
Mary C Beckerle Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,812
+19.61%
|
-
|
|
May 29
2025
|
Julie Smith Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,812
+32.27%
|
-
|
|
May 29
2025
|
Sue Gail Eckhardt Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,812
+19.61%
|
-
|
|
May 29
2025
|
Stelios Papadopoulos Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,812
+0.76%
|
-
|
|
May 29
2025
|
Maria C Freire Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,812
+8.87%
|
-
|
|
May 29
2025
|
Jack L Wyszomierski Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,812
+2.61%
|
-
|
|
May 29
2025
|
George Poste Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,812
+5.2%
|
-
|
|
May 29
2025
|
Tomas J. Heyman Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,812
+18.84%
|
-
|
|
May 21
2025
|
Tomas J. Heyman Director |
SELL
Open market or private sale
|
Direct |
4,544
-12.28%
|
$199,936
$44.29 P/Share
|
|
May 20
2025
|
Patrick J. Haley EVP, Commercial |
SELL
Open market or private sale
|
Direct |
34,387
-7.7%
|
$1,513,028
$44.06 P/Share
|
|
May 16
2025
|
Amy C. Peterson EVP Prod Dev & Med Aff & CMO |
SELL
Open market or private sale
|
Direct |
72,776
-13.52%
|
$3,274,920
$45.47 P/Share
|
|
May 16
2025
|
Amy C. Peterson EVP Prod Dev & Med Aff & CMO |
BUY
Exercise of conversion of derivative security
|
Direct |
40,000
+6.92%
|
$840,000
$21.75 P/Share
|
|
May 16
2025
|
Michael Morrissey President and CEO |
BUY
Bona fide gift
|
Indirect |
87,871
+4.53%
|
-
|
|
May 16
2025
|
Michael Morrissey President and CEO |
SELL
Bona fide gift
|
Direct |
87,871
-5.47%
|
-
|
|
May 16
2025
|
Christopher J. Senner EVP and CFO |
SELL
Open market or private sale
|
Direct |
100,000
-9.36%
|
$4,600,000
$46.0 P/Share
|
|
May 16
2025
|
Christopher J. Senner EVP and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
100,000
+8.56%
|
$1,800,000
$18.8 P/Share
|
|
May 16
2025
|
George Poste Director |
SELL
Open market or private sale
|
Direct |
20,634
-10.88%
|
$928,530
$45.99 P/Share
|
|
May 16
2025
|
George Poste Director |
BUY
Exercise of conversion of derivative security
|
Direct |
20,634
+9.81%
|
$392,046
$19.77 P/Share
|
|
May 15
2025
|
Amy C. Peterson EVP Prod Dev & Med Aff & CMO |
SELL
Payment of exercise price or tax liability
|
Direct |
8,303
-1.64%
|
$365,332
$44.65 P/Share
|
|
May 15
2025
|
Patrick J. Haley EVP, Commercial |
SELL
Open market or private sale
|
Direct |
126,383
-11.43%
|
$5,940,001
$47.5 P/Share
|
|
May 15
2025
|
Patrick J. Haley EVP, Commercial |
BUY
Exercise of conversion of derivative security
|
Direct |
116,383
+17.13%
|
$2,094,894
$18.8 P/Share
|
|
May 15
2025
|
Patrick J. Haley EVP, Commercial |
SELL
Payment of exercise price or tax liability
|
Direct |
34,705
-7.07%
|
$1,527,020
$44.65 P/Share
|
|
May 15
2025
|
Jeffrey Hessekiel EVP & General Counsel |
SELL
Open market or private sale
|
Direct |
25,000
-3.48%
|
$1,150,000
$46.18 P/Share
|
|
May 15
2025
|
Jeffrey Hessekiel EVP & General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
34,035
-4.52%
|
$1,497,540
$44.65 P/Share
|
|
May 15
2025
|
Michael Morrissey President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
104,769
-6.12%
|
$4,609,836
$44.65 P/Share
|
|
May 15
2025
|
Stelios Papadopoulos Director |
SELL
Open market or private sale
|
Direct |
36,508
-1.41%
|
$1,606,352
$44.35 P/Share
|
|
May 15
2025
|
Stelios Papadopoulos Director |
BUY
Exercise of conversion of derivative security
|
Direct |
36,508
+1.39%
|
$730,160
$20.14 P/Share
|
|
May 15
2025
|
Christopher J. Senner EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
41,422
-4.1%
|
$1,822,568
$44.65 P/Share
|
|
May 15
2025
|
Dana Aftab CSO/EVP Disc & Trans Research |
SELL
Payment of exercise price or tax liability
|
Direct |
30,693
-4.43%
|
$1,350,492
$44.65 P/Share
|
|
May 14
2025
|
Patrick J. Haley EVP, Commercial |
SELL
Open market or private sale
|
Direct |
10,000
-2.0%
|
$420,000
$42.68 P/Share
|
|
May 14
2025
|
Michael Morrissey President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
220,494
-11.42%
|
$9,701,736
$44.65 P/Share
|
|
May 14
2025
|
Michael Morrissey President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
308,365
+13.77%
|
$5,550,570
$18.8 P/Share
|